Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IDEXX LABORATORIES INC /DE Director's Dealing 2012

Apr 26, 2012

30016_dirs_2012-04-26_24f18180-f3fb-4444-beb7-69aef8e3c0c2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2012-04-24

Reporting Person: DEADY CONAN R (Corp VP, General Counsel & Sec)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-04-24 Common Stock M 2384 $41.935 Acquired 19128 Direct
2012-04-24 Common Stock M 1704 $41.935 Acquired 20832 Direct
2012-04-24 Common Stock M 3773 $34.37 Acquired 24605 Direct
2012-04-24 Common Stock M 3609 $36.09 Acquired 28214 Direct
2012-04-24 Common Stock S 14470 $85.3124 Disposed 13744 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-04-24 Incentive Stock Option (right to buy) $41.9350 M 2384 Disposed 2014-02-13 Common Stock (2384) Direct
2012-04-24 Non-Qualfied Stock Option (right to buy) $41.9350 M 1704 Disposed 2014-02-13 Common Stock (1704) Direct
2012-04-24 Non-Qualified Stock Option (right to buy) $34.37 M 3773 Disposed 2016-02-13 Common Stock (3773) Direct
2012-04-24 Non-Qualified Stock Option (right to buy) $53.31 M 3609 Disposed 2017-02-13 Common Stock (3609) Direct

Footnotes

F1: The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $85.25 to $85.42, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.

F2: Grant of options to buy shares of common stock becomes exercisable as to 218 shares on 02/14/2011, and the remaining 2,384 shares on 02/14/2012.

F3: Grant of options to buy shares of common stock becomes exercisable as to 4,088 shares on 02/14/2008, 02/14/2009 and 02/14/2010, 3,870 shares on 02/14/2011, and the remaining 1,704 shares on 02/14/2012.

F4: Grant of options to buy shares of common stock becomes exercisable as to 3,772 shares on 02/14/2010 and 02/14/2013, 3,773 shares on 02/14/2011 and 02/14/2012, and the remaining 863 shares on 02/14/2014.

F5: Grant of options to buy shares of common stock becomes exercisable as to 3,609 shares on 02/14/2011, 02/14/2012 and 02/14/2013, 3,608 shares on 02/14/2014, and the remaining 1,733 shares on 02/14/2015.